Experiment of proof-of-principle on prompt gamma-positron emission tomography (PG-PET) system for in-vivo dose distribution verification in proton therapy

  • Bo Wi Cheon
  • , Hyun Cheol Lee
  • , Sei Hwan You
  • , Hee Seo
  • , Chul Hee Min*
  • , Hyun Joon Choi*
  • *Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

Abstract

In our previous study, we proposed an integrated PG-PET-based imaging method to increase the prediction accuracy for patient dose distributions. The purpose of the present study is to experimentally validate the feasibility of the PG-PET system. Based on the detector geometry optimized in the previous study, we constructed a dual-head PG-PET system consisting of a 16 × 16 GAGG scintillator and KETEK SiPM arrays, BaSO4 reflectors, and an 8 × 8 parallel-hole tungsten collimator. The performance of this system as equipped with a proof of principle, we measured the PG and positron emission (PE) distributions from a 3 × 6 × 10 cm3 PMMA phantom for a 45 MeV proton beam. The measured depth was about 17 mm and the expected depth was 16 mm in the computation simulation under the same conditions as the measurements. In the comparison result, we can find a 1 mm difference between computation simulation and measurement. In this study, our results show the feasibility of the PG-PET system for in-vivo range verification. However, further study should be followed with the consideration of the typical measurement conditions in the clinic application.

Original languageEnglish
Pages (from-to)2018-2025
Number of pages8
JournalNuclear Engineering and Technology
Volume55
Issue number6
DOIs
StatePublished - 2023.06

Keywords

  • Detector
  • Experiment
  • In vivo dose verification
  • Positron emission tomography
  • Prompt gamma
  • Proton therapy

Quacquarelli Symonds(QS) Subject Topics

  • Engineering - Electrical & Electronic

Fingerprint

Dive into the research topics of 'Experiment of proof-of-principle on prompt gamma-positron emission tomography (PG-PET) system for in-vivo dose distribution verification in proton therapy'. Together they form a unique fingerprint.

Cite this